1
0
0
(1 - 17 von 17
)
Original Article Idarucizumab for Dabigatran ReversalThe New England Journal of Medicine
www.nejm.org
D., Jörg Kreuzer, M.D., Jerrold H. Levy, M.D., Frank W. Sellke, M.D., Joachim Stangier, Ph.D., Thorsten Steiner, M.D., M.M.E., Bushi Wang, Ph.D., Chak-Wah ... D., Jörg Kreuzer, M.D., Jerrold H. Levy, M.D., Frank W. Sellke, M.D., Joachim Stangier, Ph.D., Thorsten Steiner, M.D., M.M.E., Bushi Wang, Ph.D., Chak-Wah ...
a randomised, controlled, open-label, phase 2b/3, non- ...The Lancet
www.thelancet.com
... Jörg Kreuzer, MD, Savion Gropper, MD, Paul Reilly, PhD, Martina Brueckmann, MD, Manuela Albisetti, MD Ildar Nurmeev, Asiya Safina, Ondrej Zapletal, Leonardo Jörg Kreuzer, MD, Savion Gropper, MD, Paul Reilly, PhD, Martina Brueckmann, MD, Manuela Albisetti, MD Ildar Nurmeev, Asiya Safina, Ondrej Zapletal, Leonardo ...
a randomised, placebo-controlled, double-blind phase 1 trialThe Lancet
www.thelancet.com
... Jörg Kreuzer, MD. The Lancet. Volume 386 Issue Pages (August 2015). DOI: S (15) Copyright © Elsevier Ltd Terms and Jörg Kreuzer, MD. The Lancet. Volume 386 Issue Pages (August 2015). DOI: S (15) Copyright © Elsevier Ltd Terms and ...
Boehringer Ingelheim launches RE-VECTO global program to capture data...
www.businesswire.com
“Praxbind® received its first approval in the US nearly a year ago and is now widely available in the US, the EU and several other countries worldwide,” said Professor Jörg Kreuzer, Vice President Medicine, The…utic Area Cardiovascular, Boehringer Ingelheim. “By their nature, every emergency ...
Family Doctor Dr. Jörg Kreuzer Stock-Fotos und Bilder - Getty Images
www.gettyimages.de
Finden Sie Stock-Fotos zum Thema Family Doctor Dr. Jörg Kreuzer sowie redaktionelle Newsbilder von Getty Images. Wählen Sie aus erstklassigen Inhalten zum...
Guest Post: Industry Sponsored Editorial Assistance - Forbeswww.forbes.com › sites › larryhusten ›
www.forbes.com
· The second, by Prof Joerg Kreuzer, was that edition's "Editor's Choice" article. Prof Kreuzer's funding and conflict of interest statement ...
Relationship of stroke and bleeding risk profiles to efficacy and...
www.em-consulte.com
... Stefan H. Hohnloser, MD, Corinna Miede, MSc, Matias Nordaby, MD, Martina Brueckmann, MD, Joerg Kreuzer, MD, Takeshi Kimura, MD, PhD, Jonas Oldgren, ...
Net clinical benefit of dabigatran vs. warfarin: Nothing. Zero. | The...
www.bmj.com
Marin Feuring and Jörg Kreuzer (Boehringer-Ingelheim) published a paper (1) about the net clinical benefit of the direct oral anticoagulant ...
ESC Launches New Concept for Driving Innovation in Cardiovascular...
www.businesswire.com
ESC launches new concept for driving innovation in cardiovascular research with exclusive support from Boehringer Ingelheim
Family Doctor Dr. Jörg Kreuzer Photos and Premium High Res Pictures -...
www.gettyimages.com
Find Family Doctor Dr. Jörg Kreuzer stock photos and editorial news pictures from Getty Images. Select from premium Family Doctor Dr. Jörg Kreuzer of the...
Re: Dabigatran: how the drug company withheld important analyses |...
www.bmj.com
Joerg Kreuzer, The…utic Area Head Medicine Cardiovascular, Boehringer Ingelheim GmbH, Ingelheim, Germany Paul Reilly, Global Team ...
FDA Approves Praxbind® (idarucizumab), Specific Reversal Agent for...
www.businesswire.com
... now approved by the FDA,” said Professor Jörg Kreuzer, Vice President Medicine, The…utic Area Cardiovascular, Boehringer Ingelheim.
Favorable safety profile of Pradaxa® (dabigatran etexilate) confirmed...
www.businesswire.com
... picture of the favorable safety of dabigatran,” commented Professor Jörg Kreuzer, Vice President Medicine, The…utic Area Cardiovascular, ...
Uninterrupted Pradaxa® Showed Less Major Bleeding than Warfarin in...
www.businesswire.com
· “Once again Pradaxa® has shown safety benefits for patients compared to warfarin,” said Professor Jörg Kreuzer, Vice President Medicine, ...
New publication in The Lancet describes effective reversal of...
www.businesswire.com
Today, The Lancet published results from a healthy volunteer study investigating the reversal of the anticoagulant effect of Pradaxa® (dabigatran etex
Idarucizumab* reverses the anticoagulant effect of dabigatran within...
www.businesswire.com
Results from an interim analysis of the Phase III RE-VERSE AD™ patient study demonstrate that 5 g of idarucizumab* immediately reversed the anticoagul
Uninterrupted Pradaxa® Showed Less Major Bleeding than ...
www.businesswire.com
— “Once again Pradaxa® has shown safety benefits for patients compared to warfarin,” said Professor Jörg Kreuzer, Vice President Medicine, ... › ho...
sortiert nach Relevanz / Datum